Why is Pfizer Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.01% and Operating profit at 7.55% over the last 5 years
2
With ROE of 18.3, it has a Very Expensive valuation with a 5.9 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -7.03%, its profits have risen by 15.2% ; the PEG ratio of the company is 2.1
- At the current price, the company has a high dividend yield of 3.3
3
Below par performance in long term as well as near term
- Along with generating -7.03% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pfizer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pfizer
-21.82%
-0.25
28.65%
Sensex
-5.11%
0.43
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
2.39%
EBIT Growth (5y)
7.03%
EBIT to Interest (avg)
65.70
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
0.70
Tax Ratio
25.96%
Dividend Payout Ratio
98.34%
Pledged Shares
0
Institutional Holding
19.71%
ROCE (avg)
51.90%
ROE (avg)
17.67%
Valuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
34
Price to Book Value
4.90
EV to EBIT
20.76
EV to EBITDA
19.43
EV to Capital Employed
15.11
EV to Sales
6.97
PEG Ratio
1.37
Dividend Yield
3.66%
ROCE (Latest)
72.81%
ROE (Latest)
18.05%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
5What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 3,110.76 cr
DEBTORS TURNOVER RATIO(HY)
Highest at 13.86 times
PBDIT(Q)
Highest at Rs 235.95 cr.
PBT LESS OI(Q)
Highest at Rs 219.06 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Pfizer
Operating Profit (PBDIT) - Quarterly
Highest at Rs 235.95 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 219.06 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 3,110.76 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Highest at 13.86 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio